Analyst Reco. GSK plc Nyse

Equities

Market Closed - Nyse Other stock markets 16:00:05 2024-05-16 EDT			5-day change	1st Jan Change
44.88 ^USD	-0.98%		+1.68%	+21.10%

05-16	GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update	DJ
05-16	GSK intends to sell its remaining stake in Haleon	RE

LBBW Raises GSK PT, Reiterates Buy Rating	05-14	MT
DB and Berenberg raise Diploma price target	05-14	AN
Jefferies Keeps GSK at Buy, Lifts PT	05-13	MT
GSK : Deutsche Bank maintains a Buy rating	05-13	ZD
GSK : Receives a Buy rating from Jefferies	05-13	ZD
BAE Systems and Mondi cut to 'neutral'	05-13	AN
GSK : Receives a Buy rating from Bernstein	05-08	ZD
Bernstein Lifts GSK PT, Keeps Outperform Rating	05-08	MT
UBS raises Centrica to 'buy' from 'neutral	05-08	AN
GSK: CITIGROUP RAISES TARGET PRICE TO 2120P FROM 2100P…	05-08	RE
DZ Bank Keeps GSK at Hold, Raises PT	05-07	MT
AstraZeneca target raised; Antofagasta lowered	05-07	AN
GSK : UBS remains its Buy rating	05-06	ZD
GSK : DZ Bank remains Neutral	05-03	ZD
GSK : Buy rating from Deutsche Bank	05-02	ZD
GSK : UBS keeps its Buy rating	05-02	ZD
GSK : UBS reiterates its recommendation on the share	05-02	CF
Deutsche Bank likes TP ICAP but says sell CMC	05-02	AN
GSK : JP Morgan reaffirms its Sell rating	05-02	ZD
GSK: JP MORGAN RAISES TARGET PRICE TO 1660P FROM 1530P…	05-02	RE

No results for this search

GSK plc : Back on track

May 03, 2024 at 05:17 am

GSK PLC : Encouraging start to 2024; guidance raised